Business Context and Reporting Period
Universal Corporation (UVV) is a global business-to-business agri-products supplier, primarily known as the leading global leaf tobacco supplier and a provider of plant-based ingredients for food and beverage markets. This Form 10-Q covers the quarterly period ended September 30, 2024 (Fiscal Q2 2025) and the six months ended September 30, 2024. The Company is a Large Accelerated Filer incorporated in Virginia.
Key Financial Metrics
| Metric (in thousands, except per share) | Q2 2024 | Q2 2023 | 6 Months 2024 | 6 Months 2023 |
|---|---|---|---|---|
| Sales and Operating Revenues | $710,762 | $638,484 | $1,307,812 | $1,156,206 |
| Operating Income | $68,736 | $55,312 | $85,961 | $66,347 |
| Net Income Attributable to Universal Corp | $25,940 | $28,128 | $26,070 | $26,064 |
| Diluted EPS | $1.03 | $1.12 | $1.04 | $1.04 |
| Operating Cash Flow (6 Months) | Used: $(47,413) | Prior: Provided $10,534 | |||
| Cash and Equivalents (Sep 30, 2024) | $80,118 | |||
| Total Debt (Notes Payable + Long-Term) | $1,196,773 | |||
| Net Debt (Non-GAAP) | $1,123,492 |
Margins: Gross profit margin for the six months ended September 30, 2024, was 18.3%, down 60 basis points from 18.9% in the prior year. The effective income tax rate for the six months was 31.5% (2024) compared to 21.5% (2023).
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 11% in Q2 and 13% for the six months, driven primarily by the Tobacco Operations segment (+14% revenue, +50% operating income). Growth was fueled by strong customer demand, higher average sales prices, and larger, higher-quality crops in Africa.
- Restructuring Costs: Restructuring and impairment costs rose significantly to $10.6 million in Q2 2024 (vs. $2.6 million in Q2 2023). This was due to the consolidation of European sheet tobacco operations, specifically the wind-down of a facility in Germany.
- Ingredients Segment: The Ingredients Operations segment saw a 4% revenue decline in Q2 and a 72% drop in operating income compared to Q2 2023, attributed to unfavorable comparisons with a strong prior-year quarter and inflationary pricing pressures. However, for the six-month period, revenue grew 5% and operating income grew 52%.
- Cash Flow: Operating cash flow turned negative ($47.4 million used) for the six months ended September 30, 2024, compared to positive cash flow ($10.5 million provided) in the prior year. This was primarily due to lower customer advances and deposits ($159.7 million decrease) and seasonal working capital investments.
- Debt Levels: Short-term notes payable and overdrafts increased by $277.8 million year-over-year to $579.1 million to fund seasonal working capital needs.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects tobacco sales to be heavily weighted to the second half of fiscal year 2025. A newly expanded ingredients facility is expected to meaningfully contribute to fiscal year 2026 results. Capital expenditures are expected to be $50–$60 million over the next twelve months.
- Material Weakness in Internal Controls: The Company identified a material weakness in internal control over financial reporting due to embezzlement by a former senior finance employee at its Mozambique subsidiary. Approximately $16.7 million in unauthorized payments were identified over fiscal years 2016–2025. This resulted in delayed filings for Q2 and Q3 2025 and the loss of "well-known seasoned issuer" status and Form S-3 eligibility.
- Subsequent Events:
- Pension De-Risking: In March 2025, the Company purchased an annuity to de-risk its pension plan, triggering an expected non-cash settlement charge of approximately $15 million in Q4 2025.
- Debt Covenants: Lender consents were obtained to extend the deadline for filing delayed quarterly reports to June 16, 2025. The Company remains in compliance with financial covenants.
- Stock Repurchase: A new $100 million share repurchase program was authorized in November 2024, replacing the expiring program.
- Contingencies: The Company faces a VAT assessment in Brazil (Parana state) totaling approximately $3 million. Management believes the claim is not supported by law and has challenged it; no liability has been recorded as the loss is not considered probable.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of the remediation plan for the material weakness in Mozambique and the timeline for regaining Form S-3 eligibility.
- Working Capital Seasonality: Monitor the impact of seasonal tobacco crop purchases on cash flow and short-term debt levels in the second half of the fiscal year.
- Restructuring Execution: Track the completion of the European sheet tobacco consolidation and associated cost savings.
- Ingredients Segment Performance: Assess whether the Ingredients segment can recover from Q2 pricing pressures and volume declines in the second half of the year.
- Pension Settlement Charge: Confirm the timing and exact amount of the $15 million non-cash pension settlement charge expected in Q4 2025.